Loading
Cases by country, the UK and NHS pathway and other country lenses, and the expert centres with trials on record.
No country-level case numbers. Intrahepatic cholangiocarcinoma is inside the liver total (C22); gallbladder cancer (C23) is reported separately; extrahepatic bile duct cancer (C24) is not reported as its own site. No country-level estimate exists for biliary tract cancer as OnCo defines it.
New York · cancer center | United States | 0 | 5,120 | 95,936 | #1 | ||
Seoul · hospital | South Korea | none recorded | 2 | 1,177 | 18,820 | none recorded | #4 |
Rochester, MN · hospital | United States | 1 | 4,572 | 48,202 | #5 | ||
Villejuif · cancer center | France | none recorded | 0 | 1,862 | 31,707 | #6 | |
London · cancer center | United Kingdom | none recorded | 2 | 1,030 | 18,019 | #7 | |
Baltimore · cancer center | United States | 0 | 2,962 | 42,161 | #10 | ||
Tokyo · government | Japan | none recorded | 0 | 1,599 | 21,937 | none recorded | #13 |
Heidelberg · cancer center | Germany | none recorded | 0 | 3,473 | 46,508 | #18 | |
Seoul · hospital | South Korea | none recorded | 0 | 820 | 10,449 | #22 | |
Stanford · university | United States | 0 | 3,016 | 50,896 | #30 | ||
London · hospital | United Kingdom | none recorded | 5 | 2,376 | 28,940 | - | |
London · consortium | United Kingdom | none recorded | 4 | not matched | - | none recorded | - |
| United Kingdom | none recorded | 1 | 693 | 7,168 | - | ||
Cambridge · hospital | United Kingdom | none recorded | 1 | not matched | - | - | |
Plymouth · hospital | United Kingdom | none recorded | 1 | not matched | - | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Biliary tract cancer but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.